Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation

被引:0
|
作者
Chengyu Shi [1 ]
Ying Wang [2 ]
Minjie Wu [3 ]
Yu Chen [1 ]
Fangzhou Liu [2 ]
Zheyuan Shen [3 ]
Yiran Wang [1 ]
Shaofang Xie [2 ]
Yingying Shen [3 ]
Lingjie Sang [1 ]
Zhen Zhang [2 ]
Zerui Gao [3 ]
Luojia Yang [1 ]
Lei Qu [2 ]
Zuozhen Yang [3 ]
Xinyu He [4 ]
Yu Guo [5 ]
Chenghao Pan [1 ]
Jinxin Che [6 ]
Huaiqiang Ju [7 ]
Jian Liu [1 ]
Zhijian Cai [1 ]
Qingfeng Yan [1 ]
Luyang Yu [1 ]
Liangjing Wang [1 ]
Xiaowu Dong [1 ]
Pinglong Xu [1 ]
Jianzhong Shao [5 ]
Yang Liu [4 ]
Xu Li [5 ]
Wenqi Wang [5 ]
Ruhong Zhou [8 ]
Tianhua Zhou [9 ]
Aifu Lin [7 ]
机构
[1] Zhejiang University,MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences
[2] Zhejiang University,Cancer Center
[3] Key Laboratory for Cell and Gene Engineering of Zhejiang Province,Innovation Institute for Artificial Intelligence in Medicine
[4] Zhejiang University,Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences
[5] Zhejiang University,Key Laboratory of Structural Biology of Zhejiang Province, Westlake Laboratory of Life Sciences and Biomedicine
[6] Westlake University,Institute of Immunology
[7] Zhejiang University School of Medicine,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology
[8] Sun Yat-sen University Cancer Center,MOE Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute
[9] State Key Laboratory of Oncology in South China,Department of Developmental and Cell Biology
[10] Collaborative Innovation Center for Cancer Medicine,Shanghai Institute for Advanced Study
[11] Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute),Department of Chemistry
[12] Zhejiang University School of Medicine,Institute of Quantitative Biology
[13] International Campus,Department of Cell Biology and Program in Molecular Cell Biology
[14] Zhejiang University,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology
[15] Zhejiang University,Breast Center of the First Affiliated Hospital, School of Medicine
[16] Zhejiang University,International School of Medicine, International Institutes of Medicine
[17] University of California,undefined
[18] Zhejiang University,undefined
[19] Colombia University,undefined
[20] Zhejiang University,undefined
[21] Zhejiang University School of Medicine,undefined
[22] Zhejiang University,undefined
[23] Zhejiang University,undefined
[24] The 4th Affiliated Hospital of Zhejiang University School of Medicine,undefined
[25] ZJU-QILU Joint Research Institute,undefined
关键词
D O I
10.1038/s41467-024-55049-5
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation
    Shi, Chengyu
    Wang, Ying
    Wu, Minjie
    Chen, Yu
    Liu, Fangzhou
    Shen, Zheyuan
    Wang, Yiran
    Xie, Shaofang
    Shen, Yingying
    Sang, Lingjie
    Zhang, Zhen
    Gao, Zerui
    Yang, Luojia
    Qu, Lei
    Yang, Zuozhen
    He, Xinyu
    Guo, Yu
    Pan, Chenghao
    Che, Jinxin
    Ju, Huaiqiang
    Liu, Jian
    Cai, Zhijian
    Yan, Qingfeng
    Yu, Luyang
    Wang, Liangjing
    Dong, Xiaowu
    Xu, Pinglong
    Shao, Jianzhong
    Liu, Yang
    Li, Xu
    Wang, Wenqi
    Zhou, Ruhong
    Zhou, Tianhua
    Lin, Aifu
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
    Dahan, Rony
    Sega, Emanuela
    Engelhardt, John
    Selby, Mark
    Korman, Alan J.
    Ravetch, Jeffrey V.
    CANCER CELL, 2015, 28 (03) : 285 - 295
  • [3] Targeting the intrinsic signaling of PD-L1 in human monocytes by a novel PD-L1 antibody to promote anti-tumor immunity.
    Hsu, Michelle A.
    Liu, Xin
    Barham, Whitney
    Hirdler, Jacob
    Mao, Zhiming
    Lucien, Fabrice
    Dong, Haidong
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [4] ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
    Youqian Wu
    Chao Zhang
    Xiaolan Liu
    Zhengfu He
    Bing Shan
    Qingxin Zeng
    Qingwei Zhao
    Huaying Zhu
    Hongwei Liao
    Xufeng Cen
    Xiaoyan Xu
    Mengmeng Zhang
    Tingjun Hou
    Zhe Wang
    Huanhuan Yan
    Shuying Yang
    Yaqin Sun
    Yanying Chen
    Ronghai Wu
    Tingxue Xie
    Wei Chen
    Ayaz Najafov
    Songmin Ying
    Hongguang Xia
    Nature Communications, 12
  • [5] ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
    Wu, Youqian
    Zhang, Chao
    Liu, Xiaolan
    He, Zhengfu
    Shan, Bing
    Zeng, Qingxin
    Zhao, Qingwei
    Zhu, Huaying
    Liao, Hongwei
    Cen, Xufeng
    Xu, Xiaoyan
    Zhang, Mengmeng
    Hou, Tingjun
    Wang, Zhe
    Yan, Huanhuan
    Yang, Shuying
    Sun, Yaqin
    Chen, Yanying
    Wu, Ronghai
    Xie, Tingxue
    Chen, Wei
    Najafov, Ayaz
    Ying, Songmin
    Xia, Hongguang
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
    Topalian, Suzanne L.
    Drake, Charles G.
    Pardoll, Drew M.
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (02) : 207 - 212
  • [7] Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation
    Xu, Xiaoyan
    Xie, Tingxue
    Zhou, Mengxin
    Sun, Yaqin
    Wang, Fengqi
    Tian, Yanan
    Chen, Ziyan
    Xie, Yanqi
    Wu, Ronghai
    Cen, Xufeng
    Zhou, Jichun
    Hou, Tingjun
    Zhang, Lei
    Huang, Chaoyang
    Zhao, Qingwei
    Wang, Dongrui
    Xia, Hongguang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [8] Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
    Poggio, Mauro
    Hu, Tianyi
    Pai, Chien-Chun
    Chu, Brandon
    Belair, Cassandra D.
    Chang, Anthony
    Montabana, Elizabeth
    Lang, Ursula E.
    Fu, Qi
    Fong, Lawrence
    Blelloch, Robert
    CELL, 2019, 177 (02) : 414 - +
  • [9] A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice
    Pan, Jiayi
    Zeng, Wuyi
    Jia, Jiangtao
    Shi, Yi
    Wang, Danni
    Dong, Jun
    Fang, Zixuan
    He, Jiashan
    Yang, Xinyu
    Zhang, Rong
    He, Menghua
    Huang, Maoping
    Fu, Bishi
    Zhong, Bei
    Liu, Hui
    VACCINES, 2022, 10 (07)
  • [10] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
    Li, Jinghan
    Shi, Daiwang
    Li, Siyi
    Shi, Xiang
    Liu, Yu
    Zhang, Yi
    Wang, Gebang
    Zhang, Chenlei
    Xia, Tian
    Piao, Hai-long
    Liu, Hong-Xu
    CELL DEATH & DISEASE, 2024, 15 (02)